Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001171843-17-001288
Filing Date
2017-03-03
Accepted
2017-03-03 15:37:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 f424b5_030317.htm 424B5 212905
2 GRAPHIC logo.jpg GRAPHIC 24080
  Complete submission text file 0001171843-17-001288.txt   246497
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-213218 | Film No.: 17663266
SIC: 2834 Pharmaceutical Preparations